Michael e. B. Spicer

All filings by Michael e. B. Spicer on record concern Novadel Pharma Inc. We count 6 filings; the first trade dates from 29 December 2005 and the latest from 6 February 2008.

Purchases make up the whole of the open-market record (5 purchases, €21k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant.

A typical purchase (the median) is worth €1,920.

The record was last updated on 7 February 2008 with a share grant in Novadel Pharma Inc. The clock since the last published purchase (21 August 2007) now reads 7,004 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.